Panel Discussion March 4 on Steroids, HGH, and the Future of Baseball
The recently released Mitchell Report has brought national attention to the role of performance enhancing substances in baseball. An interdisciplinary panel of experts will examine the Mitchell Report from medical, legal, business, and media perspectives, considering: What did the Mitchell Report actually say? What are its implications for baseball and for other sports? And how should professional sports address the issue of performance enhancing substances in the future?
Panelists taking part in the discussion are:
--Jimmy Golen '99 MSL, reporter for The Associated Press who covers sports in Boston. He has covered five Super Bowls, three Olympics, and three World Series, including the Red Sox victories in 2004 and 2007.
--Dr. Peter Jokl, professor and vice-chairman of the Yale Department of Orthopaedics and Rehabilitation, and the section chief of Yale Sports Medicine. He is former president of the American Academy of Sports Physicians.
--Professor Michael McCann of the Mississippi College School of Law. He is chair of the Association of American Law Schools’ Section on Sports and the Law, and author of the “Sports and the Law” column on SI.com.
--Joe Ravitch ’88, managing director in the Investment Banking Division of Goldman Sachs. He is responsible for the media and entertainment sector within the firm’s Telecom, Media and Technology group.
The panel discussion is co-sponsored by the Yale Entertainment Sports Law Association and the Yale Law School Dean’s Office. It is free and open to the public.